Abstract
Most blood group antigens are defined by single nucleotide polymorphisms (SNPs). Highly accurate MALDI-TOF MS has proven its potential in SNP genotyping and was therefore chosen for blood donor oriented genotyping with high-throughput capability, e.g., 380 samples per day. The Select Module covers a total of 36 SNPs in two single-tube reactions, representative of 46 blood group and 4 human platelet antigens. Using this tool, confirmatory blood group typing for RhD, RhCE, Kell, Kidd, Duffy, MN, Ss, and selected rare antigens is performed on a routine basis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Daniels G (2013) Human blood groups, 3rd edn. Blackwell Science, Oxford
Committee on Terminology for RBC Surface Antigens [database on the Internet] (2012) http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/blood-group-terminology/blood-group-allele-terminology/
Denomme GA, Johnson ST, Pietz BC (2011) Mass-scale red cell genotyping of blood donors. Transfus Apher Sci 44:93–99
Halverson GR, Peyrard T (2010) A review of the Colton blood group system. Immunohematology 26:22–26
Yamamoto F, Clausen H, White T, Marken J, Hakomori S (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345:229–233
dbSNP, NCBI Build 138, Phase I [database on the Internet] (2013) http://www.ncbi.nlm.nih.gov/projects/SNP/
Mouro I, Colin Y, Cherif-Zahar B, Cartron JP, Le Van Kim C (1993) Molecular genetic basis of the human Rhesus blood group system. Nat Genet 5:62–65
Reid ME (2009) MNS blood group system: a review. Immunohematology 25:95–101
Gassner C, Schmarda A, Kilga-Nogler S, Jenny-Feldkircher B, Rainer E, Muller TH et al (1997) RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 37:1020–1026
Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA (1998) Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood 91:2157–2168
Wagner FF, Frohmajer A, Flegel WA (2001) RHD positive haplotypes in D negative Europeans. BMC Genet 2:10
Gassner C, Utz I, Schennach H, Ramoni A, Steiner H, Scholz S et al (2013) Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76. Transfusion 53(Suppl 2):2954–2959
Amado M, Bennett EP, Carneiro F, Clausen H (2000) Characterization of the histo-blood group O(2) gene and its protein product. Vox Sang 79:219–226
Kormoczi GF, Wagner T, Jungbauer C, Vadon M, Ahrens N, Moll W et al (2007) Genetic diversity of KELnull and KELel: a nationwide Austrian survey. Transfusion 47:703–714
Saison C, Helias V, Ballif BA, Peyrard T, Puy H, Miyazaki T et al (2012) Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet 44:174–177
Zelinski T, Coghlan G, Liu XQ, Reid ME (2012) ABCG2 null alleles define the Jr(a-) blood group phenotype. Nat Genet 44:131–132
Helias V, Saison C, Ballif BA, Peyrard T, Takahashi J, Takahashi H et al (2012) ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis. Nat Genet 44:170–173
Haer-Wigman L, Ji Y, Loden M, de Haas M, van der Schoot CE, Veldhuisen B (2013) Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy. Transfusion 53(Suppl 2):2899–2909
Gowland P, Gassner C, Hustinx H, Stolz M, Gottschalk J, Tissot JD et al (2014) Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci 50:163–168
Tang K, Fu D, Kotter S, Cotter RJ, Cantor CR, Koster H (1995) Matrix-assisted laser desorption/ionization mass spectrometry of immobilized duplex DNA probes. Nucleic Acids Res 23:3126–3131
Jurinke C, van den Boom D, Cantor CR, Koster H (2002) The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 77:57–74
Li Y, Wenzel F, Holzgreve W, Hahn S (2006) Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation. Electrophoresis 27:3889–3896
Fumagalli D, Gavin PG, Taniyama Y, Kim SI, Choi HJ, Paik S et al (2010) A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes. BMC Cancer 10:101
Garritsen HS, Xiu-Cheng Fan A, Lenz D, Hannig H, Yan Zhong X, Geffers R et al (2009) Molecular diagnostics in transfusion medicine: in capillary, on a chip, in silico, or in flight? Transfus Med Hemother 36:181–187
Vivante A, Amariglio N, Koren-Michowitz M, Ashur-Fabian O, Nagler A, Rechavi G et al (2007) High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations. Leukemia 21:1318–1321
Cerezo M, Cerny V, Carracedo A, Salas A (2009) Applications of MALDI-TOF MS to large-scale human mtDNA population-based studies. Electrophoresis 30:3665–3673
Xiu-Cheng Fan A, Garritsen HS, Tarhouny SE, Morris M, Hahn S, Holzgreve W et al (2008) A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry. Clin Chem Lab Med 46:299–305
Jaremko M, Justenhoven C, Abraham BK, Schroth W, Fritz P, Brod S et al (2005) MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum Mutat 25:232–238
Docherty SJ, Davis OS, Haworth CM, Plomin R, Mill J (2010) DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA. Methods 52:255–258
Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W (2008) Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenatal Diagn 28:203–208
Bombard AT, Akolekar R, Farkas DH, Van Agtmael AL, Aquino F, Oeth P et al (2011) Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenatal Diagn 31:802–808
Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M (2006) High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 46:841–848
Garritsen HS, Fan AX, Bosse N, Hannig H, Kelsch R, Kroll H et al (2009) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for genotyping of human platelet-specific antigens. Transfusion 49:252–258
Gassner C, Meyer S, Frey BM, Vollmert C (2013) Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping–the alternative approach. Transfus Med Rev 27:2–9
Lopez GH, McBean RS, Wilson B, Irwin DL, Liew YW, Hyland CA et al (2014) Molecular typing for the Indian blood group associated 252G>C single nucleotide polymorphism in a selected cohort of Australian blood donors. Blood Transfus 18:1–8
Meyer S, Vollmert C, Trost N, Bronnimann C, Gottschalk J, Buser A et al (2014) High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry-based blood group genotyping of 4,000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 54(12):3198–3207
Santos FR, Pandya A, Tyler-Smith C (1998) Reliability of DNA-based sex tests. Nat Genet 18:103
Blood Donation Service Switzerland SRC. Guidelines of the Swiss Red Cross Blood Donation Service (2013) Chapter 11 B, immuno-haematological donor typing. https://sbsc-bsd.ch/dokuman/DokumenteBSD/Allgemeines/tabid/107/language/de/Default.aspx
Crottet SL, Henny C, Meyer S, Still F, Stolz M, Gottschalk J et al (2014) Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci 50:169–174
Online Mendelian Inheritance of Men [database on the Internet] (2014) http://www.ncbi.nlm.nih.gov/omim/
Acknowledgements
Financial support for the development of the Select Module was granted by the Humanitarian Foundation of the Swiss Red Cross (SRC); the Blood Transfusion Service Zurich, SRC, Switzerland and the Swiss blood transfusion umbrella organization Blutspende SRK Schweiz, Bern, Switzerland. SM, NT, and BMF are employees of the Blood Transfusion Service Zurich, SRC, Switzerland, and have not disclosed any conflicts of interest. CG is employee of the Blood Transfusion Service Zurich, SRC, Switzerland, and acts as a consultant for Inno-Train GmbH, Kronberg im Taunus, Germany.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Meyer, S., Trost, N., Frey, B.M., Gassner, C. (2015). Parallel Donor Genotyping for 46 Selected Blood Group and 4 Human Platelet Antigens Using High-Throughput MALDI-TOF Mass Spectrometry. In: Bugert, P. (eds) Molecular Typing of Blood Cell Antigens. Methods in Molecular Biology, vol 1310. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2690-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2690-9_5
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2689-3
Online ISBN: 978-1-4939-2690-9
eBook Packages: Springer Protocols